Newsletter – April 2026
Q1 to Q2: Turning SaaS Momentum into Predictable ARR
The first quarter doesn’t define your year.
It reveals how you’re building it.
Q1 is where assumptions get tested. Where momentum meets reality. And where the strongest founders start to separate growth that looks good on paper from growth that actually lasts.
What we’ve seen so far this year is a continued shift in how companies are being built and evaluated. The conversation is moving beyond simply being a SaaS business. It is becoming centered around something more specific and more important: recurring revenue.
SaaS defines how software is delivered.
Recurring revenue defines how a business scales.
The founders who are navigating this environment well are not chasing growth alone. They are focused on building durable Annual Recurring Revenue. They are strengthening retention, improving expansion, and creating revenue streams that compound over time. They are making decisions that support predictability, not just performance.
This is where real enterprise value is created.
This month, we’re leaning into that theme of intentional growth and durable revenue.
In our latest article, “Intentional SaaS Growth Strategy: How Founders Build Scalable and Profitable Companies,” we break down what it takes to move from reactive growth to a structured, scalable model built around strong recurring revenue.
We also expand on how this applies today in “Intentional SaaS Growth in 2026: How Founders Turn Q1 Insights Into Scalable Revenue,” where we focus on how founders can use Q1 insights to strengthen ARR and build a more predictable path forward.
Both are designed to give founders a clear, practical perspective on how to build momentum that lasts.
RevTek Capital recently announced its fourth growth capital credit facility for Apex Biologix, reinforcing a long-term partnership built around intentional scaling.
This continued investment reflects how the right capital, at the right time, supports every stage of growth, from expansion to operational scale. Apex Biologix continues to lead in regenerative medicine, building with consistency and a focus on long-term enterprise value.
This is how we partner with founders.
Throughout April, our LinkedIn content will continue to share practical insights on how founders can refine strategy, strengthen revenue quality, and scale with precision after Q1. Be sure to follow RevTek Capital on LinkedIn to stay connected.
As we move into Q2, the opportunity is not to simply accelerate. It is to build with more precision. To focus on what is working, refine what is not, and create a foundation rooted in durable, recurring revenue.
At RevTek Capital, we work with founders who are building companies this way. Not just growing, but creating scalable revenue models designed for long-term success.
Looking forward to what you build next.
Build with precision. Fund with confidence. Grow with RevTek.
Apply for Growth Capital → RevTekCapital.com
Sincerely,
Scott Peters
and The RevTek Capital Team
“Helping founders realize their vision”
RevTek Capital Closes Fourth Financing Round with Apex Biologix
RevTek Capital recently announced its fourth growth capital credit facility for Apex Biologix, reinforcing a long-term partnership built around intentional scaling. This continued investment highlights how access to the right capital at the right time can support every stage of growth, from expansion to operational scale. Apex Biologix continues to lead in regenerative medicine, building with consistency and a focus on long-term enterprise value.
Intentional ARR Growth in 2026: How Founders Turn Q1 Insights Into Scalable Revenue
Q1 doesn’t just measure growth. It reveals how your business is actually built. The strongest founders use this moment to refine what’s driving their revenue, strengthen retention, and build more durable ARR. Because in today’s market, growth alone isn’t enough. It has to be predictable, scalable, and built to last. In this article, we break down how founders are shifting from momentum to precision and building revenue engines designed for long-term success.
Intentional SaaS Growth Strategy: How Founders Build Scalable and Profitable Companies
After Q1, growth alone isn’t enough. Founders are being pushed to build companies that are not just scalable, but profitable. This article breaks down how SaaS founders are approaching growth with more intention, focusing on efficiency, strong unit economics, and building businesses that are designed to scale long term.
From Our LinkedIn Community
How Founders Build Durable ARR Between Funding Rounds
One of the most important phases of building a SaaS company happens between funding rounds.
This is where durable value is created.
The founders who scale successfully during this stage tend to focus on a few key priorities:
✅ Strengthening customer retention and expanding revenue
✅ Improving CAC efficiency before increasing acquisition spend
✅ Expanding product capabilities based on real customer usage
✅ Building a repeatable go-to-market motion
✅ Investing capital in initiatives directly tied to ARR growth
Growth between funding rounds isn’t about slowing down.
It’s about building the operational discipline and attention to the right details that compound revenue over time.
At RevTekCapital, we work with SaaS founders who are scaling through this exact phase, helping provide strategic growth capital that supports their next stage of expansion.
Because the strongest SaaS companies aren’t built in a single funding event.
They’re built through disciplined growth over time.
RevTek Capital is a leading strategic credit funding source for SaaS and tech-enabled companies with predictable recurring revenue. We’ve raised rounds, managed burn, and hit milestones. We have had to stress about making payroll. Now we help founders like you do the same.
We leverage our years of early-stage entrepreneuring, lending, and investing experiences to provide customized credit solutions to growing companies with predictable recurring revenue/subscription-based business models. Our goal is to help entrepreneurs grow their business and preserve equity while maximizing enterprise value for all stakeholders. We are the alternative to and complement with venture capital.
RevTek’s focus is providing $2MM to $20MM+ for growing companies with $5MM to $75MM in predictable annual recurring revenue. Motivating management teams and allowing investors to maximize investment returns is a key objective. RevTek’s process is always relationship-driven, and our long-term lending strategy has proven effective for companies in our portfolio.
Be assured that by doing business with RevTek Capital, you are doing business with one of the strongest strategic credit funding sources in the lending market. We have earned a strong reputation, reinforcing the value we deliver and continuity for funding the ongoing growth of the companies we serve. Our track record confirms we pick winners and fully support them.
If you are seeking to secure growth capital or complete an acquisition, please contact us today. We don’t want to own your business. We help you grow your business.